Zobrazeno 1 - 10
of 252
pro vyhledávání: '"Lee N Newcomer"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Barbara J. Culliton
Publikováno v:
Health Affairs. 26:w41-w51
New drugs for cancer, targeted at the specific genetic profile of various tumors, are revolutionizing cancer therapy, but at a very high cost. Most carry a price tag of $50,000 or more per patient per year. Lee Newcomer examines the medical and polic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b1754db7828d3dca49f5b1fcc338b3c
https://doi.org/10.1377/hlthaff.27.1.w41
https://doi.org/10.1377/hlthaff.27.1.w41
Autor:
Newcomer LN
Publikováno v:
Managed care (Langhorne, Pa.) [Manag Care] 2011 Dec; Vol. 20 (12), pp. 36-40.
Autor:
Newcomer LN
Publikováno v:
Health affairs (Project Hope) [Health Aff (Millwood)] 2008 Jan-Feb; Vol. 27 (1), pp. w41-51. Date of Electronic Publication: 2007 Nov 27.
Autor:
Guttridge, G. H.
Publikováno v:
The English Historical Review, 1953 Oct 01. 68(269), 651-651.
Externí odkaz:
https://www.jstor.org/stable/556804
Publikováno v:
Health Affairs. 38:812-819
The high and rising costs of anticancer drugs have received national attention. The prices of brand-name anticancer drugs often dwarf those of established generic drugs with similar efficacy. In 2007-16 UnitedHealthcare sought to encourage the use of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::db271f82b8d2113befee7ba86b4c322a
https://doi.org/10.1377/hlthaff.2018.05083
https://doi.org/10.1377/hlthaff.2018.05083
Autor:
Lee N Newcomer
Publikováno v:
Cancer journal (Sudbury, Mass.). 26(4)
Chemotherapy and supportive drugs constitute 70% of a cancer patient's medical costs during active therapy. Payers use several approaches to keep those costs affordable including paying lower margins for "buy and bill" oncologists, prior authorizatio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72335162362cbe272a7ef41db2921506
https://pubmed.ncbi.nlm.nih.gov/32732670
https://pubmed.ncbi.nlm.nih.gov/32732670
Autor:
Lee N. Newcomer
Publikováno v:
JCO oncology practice. 16(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb2737611fb544eec58a213f31d883df
https://pubmed.ncbi.nlm.nih.gov/32302272
https://pubmed.ncbi.nlm.nih.gov/32302272
Autor:
Benjamin Chastek, Stephanie Korrer, Jennifer Malin, Lee N. Newcomer, Thomas Horstman, Stacey DaCosta Byfield
Although physicians rely on clinical trial data to guide cancer treatment decisions, patient characteristics and outcomes often differ between real-world and clinical trial populations. We analyzed retrospective clinical data collected from a prior a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b41b01e63d2a4be6fed2e1b8d30ea119
